Royality Med's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Royality Med's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@royalitymedgrp.com
Contact Us
UK HEADQUARTERS
51-34 Nottingham Pl, London W1U 5NY, United Kingdom
info@royalitymedgrp.com
+ 44 7940 915467
US Branch
7-11 w 29th, New York, Ny 10001-4504, United States
support@royalitymedgrp.com
+ 1 812-919-6983
I would like to learn about Royality Med’s Pharmaceuticals Group discoveries to treat genetic diseases.